Investigation of the causal relationships between human IgG N-glycosylation and 12 common diseases associated with changes in the IgG N-glycome. Issue 10 (15th November 2021)

• Record Type: Journal Article
• Authors: Zaytseva, Olga O; Sharapov, Sodbo Zh; Perola, Marcus; Esko, Tonu; Landini, Arianna; Hayward, Caroline; Wilson, James F; Lauc, Gordan; Aulchenko, Yurii S; Klarić, Lucija; Tsepilov, Yakov A
• Is Part Of: Human molecular genetics. Volume 31:Issue 10(2022)
• Page Start: 1545
• Page End: 1559
• Publication Date: 2021-11-15
• Subjects: Human molecular genetics -- Periodicals; Human chromosome abnormalities -- Periodicals; 572.8
• DOI: 10.1093/hmg/ddab335
• Languages: English
• ISSNs: 0964-6906

Abstract

Abstract: Changes in the N-glycosylation of immunoglobulin G (IgG) are often observed in pathological states, such as autoimmune, inflammatory, neurodegenerative, cardiovascular diseases and some types of cancer. However, in most cases, it is not clear if the disease onset causes these changes, or if the changes in IgG N-glycosylation are among the risk factors for the diseases. The aim of this study was to investigate the casual relationships between IgG N-glycosylation traits and 12 diseases, in which the alterations of IgG N-glycome were previously reported, using two sample Mendelian randomization (MR) approach. We have performed two sample MR using publicly available summary statistics of genome-wide association studies of IgG N-glycosylation and disease risks. Our results indicate positive causal effect of systemic lupus erythematosus (SLE) on the abundance of N-glycans with bisecting N- acetylglucosamine in the total IgG N-glycome. Therefore, we suggest regarding this IgG glycosylation trait as a biomarker of SLE. We also emphasize the need for more powerful GWAS studies of IgG N-glycosylation to further elucidate the causal effect of IgG N-glycome on the diseases.